MGS Mfg. Group Inc., a Germantown, Wis.-based custom injection molder and toolmaker, is investing $20 million at its headquarters site and closing two Illinois operations as it focuses more on capabilities and clean room capacity for customers in the health care market.
A new 13,000-square-foot Class 8 clean room will house 20 injection molding machines with press tonnage from 160-650 tons, automated assembly cells and auxiliary equipment.
Called the Healthcare Center of Excellence, the facility was designed to bring together MGS's U.S.-based tooling, molding and equipment divisions under one roof to share resources and help customers.
"This center strategically positions us to continue setting the industry standard of excellence across each area of our business while answering customer demands for an integrated, single source of supply," MGS CEO Greg Adams said in a statement. "By combining our tooling, molding and equipment technologies, we increase accountability and decrease complexity — driving down costs, increasing speed-to-market, mitigating risk and transferring knowledge from one area of our business to the next. We need to deliver excellence all the way from pellet to patient."
The center will be completed later this year.
In the meantime, MGS is consolidating its Illinois operations into the Germantown facility.
The company currently has two sites in northern Illinois: Antioch and Libertyville. Both are about 70 miles from Germantown.
Illinois employees will be offered positions within the Germantown operations.
"Combining our teams on a single campus opens up significant opportunities for employees to expand their knowledge and leverage their expertise in new and increasingly meaningful ways," MGS President Paul Manley said in a statement. "Enhanced collaboration and cross-functional teams will drive the innovation and entrepreneurial spirit that has been a hallmark of MGS since its inception."
MGS has 1,800 employees at six manufacturing facilities in the U.S., Mexico and Ireland. It has annual sales of about $200 million and 260 presses within its global fleet. It ranked No. 50 in the most recent Plastics News survey of North American injection molders.
The company is owned by Mason Wells, a Milwaukee-based private equity firm.